Answer
In allergic asthma trials involving children aged 6 to 11 years, the most commonly reported adverse reactions to omalizumab were headache, pyrexia (fever) and upper abdominal pain.
Sources for this answer
- Xolair 150mg Solution for Injection in pre-filled syringeNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 22Document updated
Sources checked